SynthesisCancer immunology, immunotherapy : CII2024

Efficacy and safety of anti-PD-1/PD-L1-based dual immunotherapies versus PD-1/PD-L1 inhibitor alone in patients with advanced solid tumor: a systematic review and meta-analysis.

Yueying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.